Updated Jul 16, 2026
FOUSE JACQUALYN A has filed 3 SEC Form 4 filings across 3 companies in the last 90 days.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-23 | AGIO | AGIOS PHARMACEUTICALS, INC. | M — Option exercise | 2.8K | $0.00 | |
| 2026-06-18 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | A — Grant or award | 454 | $0.00 | |
| 2026-06-10 | INCY | INCYTE CORP | A — Grant or award | 1.6K | $0.00 | |
| 2025-06-20 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | A — Grant or award | 203 | $0.00 |
FOUSE JACQUALYN A is a corporate insider — currently tracked as Director of AGIOS PHARMACEUTICALS, INC. (AGIO). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 3 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live FOUSE JACQUALYN A profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.